Your browser doesn't support javascript.
loading
Health care services utilization in patients with ovarian cancer receiving PARP inhibitor maintenance treatment in a US community oncology setting.
Chase, Dana M; Annavarapu, Srinivas; Tseng, Wan-Yu; Shi, Junxin; Szamreta, Elizabeth; Monberg, Matthew.
Afiliação
  • Chase DM; Division of Gynecologic Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America. Electronic address: dmchase@mednet.ucla.edu.
  • Annavarapu S; Ontada, Irving, TX, USA. Electronic address: Srinivas.Annavarapu@McKesson.com.
  • Tseng WY; Ontada, Irving, TX, USA. Electronic address: Wan-Yu.Tseng@McKesson.com.
  • Shi J; Ontada, Irving, TX, USA. Electronic address: Junxin.Shi@McKesson.com.
  • Szamreta E; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: Elizabeth.Szamreta@Merck.com.
  • Monberg M; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: Matthew.Monberg@Merck.com.
Gynecol Oncol ; 180: 79-85, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38056115
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Limite: Adolescent / Adult / Aged / Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Limite: Adolescent / Adult / Aged / Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article